Terms: = Prostate cancer AND MYD88, Q99836, MYD88D, 4615
19 results:
1. Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy cancer Patients.
O'Brien G; Kamuda M; Cruz-Garcia L; Polozova M; Tichy A; Markova M; Sirak I; Zahradnicek O; Widłak P; Ponge L; Polanska J; Badie C
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256152
[TBL] [Abstract] [Full Text] [Related]
2. Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.
Wang S; Huang M; Chen M; Sun Z; Jiao Y; Ye G; Pan J; Ye W; Zhao J; Zhang D
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37295817
[TBL] [Abstract] [Full Text] [Related]
3. Tempol differential effect on prostate cancer inflammation: In vitro and in vivo evaluation.
Rossetto I; Santos F; Kido L; Lamas C; Montico F; Cagnon V
Prostate; 2023 Apr; 83(5):403-415. PubMed ID: 36546327
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors.
Bagherian Z; Mirshafiey A; Mohsenzadegan M; Farajollahi MM
Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):254-263. PubMed ID: 34699087
[TBL] [Abstract] [Full Text] [Related]
5. Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cell.
Mohsenzadegan M; Moghbeli F; Mirshafiey A; Farajollahi MM
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):419-430. PubMed ID: 34057866
[No Abstract] [Full Text] [Related]
6. Engineering Tolerance toward Allogeneic CAR-T Cells by Regulation of MHC Surface Expression with Human Herpes Virus-8 Proteins.
Wang X; Cabrera FG; Sharp KL; Spencer DM; Foster AE; Bayle JH
Mol Ther; 2021 Feb; 29(2):718-733. PubMed ID: 33554868
[TBL] [Abstract] [Full Text] [Related]
7. prostate cancer Risk by BRCA2 Genomic Regions.
Nyberg T; Frost D; Barrowdale D; Evans DG; Bancroft E; Adlard J; Ahmed M; Barwell J; Brady AF; Brewer C; Cook J; Davidson R; Donaldson A; Eason J; Gregory H; Henderson A; Izatt L; Kennedy MJ; Miller C; Morrison PJ; Murray A; Ong KR; Porteous M; Pottinger C; Rogers MT; Side L; Snape K; Tripathi V; Walker L; Tischkowitz M; Eeles R; Easton DF; Antoniou AC
Eur Urol; 2020 Oct; 78(4):494-497. PubMed ID: 32532514
[TBL] [Abstract] [Full Text] [Related]
8. CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the myd88/NF-κB signaling.
Jin X; Shi Q; Li Q; Zhou L; Wang J; Jiang L; Zhao X; Feng K; Lin T; Lin Z; Zhuang H; Yang J; Hu C; Zhang L; Shen L; Lu Y; Zhu J; Wang H; Qi H; Meng X; Xi Y; Pan J; Fang S; Tian H; Zhou C; Zhang P; Gao K; Zhao SM; Li Y; Gong Z; Wang C
Leukemia; 2020 May; 34(5):1305-1314. PubMed ID: 31776466
[TBL] [Abstract] [Full Text] [Related]
9. MPSSS impairs the immunosuppressive function of cancer-associated fibroblasts via the TLR4-NF-κB pathway.
Xu Y; Ma J; Zheng Q; Wang Y; Hu M; Ma F; Qin Z; Lei N; Tao N
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992392
[TBL] [Abstract] [Full Text] [Related]
10. RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine prostate cancer Progression.
Li Y; Xie N; Chen R; Lee AR; Lovnicki J; Morrison EA; Fazli L; Zhang Q; Musselman CA; Wang Y; Huang J; Gleave ME; Collins C; Dong X
Eur Urol; 2019 Aug; 76(2):157-166. PubMed ID: 30910347
[TBL] [Abstract] [Full Text] [Related]
11. Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated prostate cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.
Salimu J; Spary LK; Al-Taei S; Clayton A; Mason MD; Staffurth J; Tabi Z
Cancer Immunol Res; 2015 Jun; 3(6):678-88. PubMed ID: 25678582
[TBL] [Abstract] [Full Text] [Related]
12. Chlamydia trachomatis infection increases the expression of inflammatory tumorigenic cytokines and chemokines as well as components of the Toll-like receptor and NF-κB pathways in human prostate epithelial cells.
Sellami H; Said-Sadier N; Znazen A; Gdoura R; Ojcius DM; Hammami A
Mol Cell Probes; 2014 Aug; 28(4):147-54. PubMed ID: 24613856
[TBL] [Abstract] [Full Text] [Related]
13. Innate immunity gene polymorphisms and the risk of colorectal neoplasia.
Chang CM; Chia VM; Gunter MJ; Zanetti KA; Ryan BM; Goodman JE; Harris CC; Weissfeld J; Huang WY; Chanock S; Yeager M; Hayes RB; Berndt SI;
Carcinogenesis; 2013 Nov; 34(11):2512-20. PubMed ID: 23803696
[TBL] [Abstract] [Full Text] [Related]
14. Mutational and expressional analyses of myd88 gene in common solid cancers.
Je EM; Kim SS; Yoo NJ; Lee SH
Tumori; 2012; 98(5):663-9. PubMed ID: 23235763
[TBL] [Abstract] [Full Text] [Related]
15. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract] [Full Text] [Related]
16. Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.
Gatti G; Quintar AA; Andreani V; Nicola JP; Maldonado CA; Masini-Repiso AM; Rivero VE; Maccioni M
Prostate; 2009 Sep; 69(13):1387-97. PubMed ID: 19496069
[TBL] [Abstract] [Full Text] [Related]
17. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.
Peng G; Wang HY; Peng W; Kiniwa Y; Seo KH; Wang RF
Immunity; 2007 Aug; 27(2):334-48. PubMed ID: 17656116
[TBL] [Abstract] [Full Text] [Related]
18. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and myd88-deficient mice.
Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
[TBL] [Abstract] [Full Text] [Related]
19. Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide.
Hassan F; Islam S; Tumurkhuu G; Naiki Y; Koide N; Mori I; Yoshida T; Yokochi T
BMC Cancer; 2006 Dec; 6():281. PubMed ID: 17156435
[TBL] [Abstract] [Full Text] [Related]
